BioNTech SE from Mainz has successfully made the leap to the American technology exchange Nasdaq. The company made its debut on the stock exchange and raised 150 million US-dollars.
The Mainz-based biotech company BioNTech SE does not lack in prominent investors. The Bill and Melinda Gates Foundation is now investing $55 million. And the amount can still grow to $10
Once again, the Mainz-based company BioNTech has secured a sum in the hundred-million-euro range. Two thirds of the capital was contributed by new investors.
BioNTech SE announces the start of clinical development for its drug candidate DuoBody PD-L1x4-1BB.
With the help of investors both new and old, the Freiburg-based start-up is taking the next big step in the introduction of its innovative technology for the rapid detection of multi-resi